Synonyms: compound 19 [WO2023018643A1]
Compound class:
Synthetic organic
Comment: The chemical structure for fosizensertib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a receptor-interacting serine/threonine protein kinase 1 (RIPK1) inhibitor. This generated a SMILES match via PubChem to a compound (19) claimed in patent WO2023018643A1 (AbbVie) [1]. This appears to be a phosphate prodrug, that is dephosphorylated in vivo, to the active metabolite compound 2. In the absence of formal structure disclosure (March 2025) we hypothesise that this is likely to be the INN for AbbVie's oral ulcerative colitis lead ABBV-668.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[(2S)-1-[[5-[2-[1-(difluoromethyl)pyrazol-4-yl]ethynyl]pyridine-3-carbonyl]-methylamino]-3-phenylpropan-2-yl] dihydrogen phosphate |
International Nonproprietary Names ![]() |
|
INN number | INN |
13384 | fosizensertib |
Synonyms ![]() |
compound 19 [WO2023018643A1] |
Database Links ![]() |
|
GtoPdb PubChem SID | 507750439 |
PubChem CID | 167466532 |
Search Google for chemical match using the InChIKey | AJSWMXIMACDPCV-FQEVSTJZSA-N |
Search Google for chemicals with the same backbone | AJSWMXIMACDPCV |
Search PubMed clinical trials | fosizensertib |
Search PubMed titles | fosizensertib |
Search PubMed titles/abstracts | fosizensertib |
UniChem Compound Search for chemical match using the InChIKey | AJSWMXIMACDPCV-FQEVSTJZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | AJSWMXIMACDPCV-FQEVSTJZSA-N |